Krystal Biotech KRYS
NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST

Krystal Biotech (KRYS) Return on Sales [ROS] (2017 - 2026)

Updated

Krystal Biotech (KRYS) posted Return on Sales [ROS] of 55.87% for Q3 2026, up 13.56 percentage points from 42.30% a year earlier and up 6.87 percentage points from the prior quarter.

Analysis

Krystal Biotech (KRYS) Return on Sales [ROS] (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Krystal Biotech was 48.40%, up 5.95 percentage points year-over-year; for FY2025, it was 41.45%, up 18.82 percentage points from FY2024.

  • In prior years, Krystal Biotech's Return on Sales [ROS] was 22.63% in FY2024 (+238.84 pp) and -216.21% in FY2023.
  • The Q3 2026 figure stands as the highest quarterly Return on Sales [ROS] in data going back to Q3 2023.
  • On a year-over-year basis, Return on Sales [ROS] has increased in each of the last three quarters, with an average year-over-year change of +20.05 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2024, with a gain of 330.60 percentage points; the weakest was Q4 2025, with a drop of 4.08 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 49.00% (Q2 2026), 46.12% (Q1 2026) and 41.33% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Krystal Biotech 9.08 Bn 5.67 Bn 119.79 Mn 55.87%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 55.87%
Jun 30, 2026 49.00%
Mar 31, 2026 46.12%
Dec 31, 2025 41.33%
Sep 30, 2025 42.30%
Jun 30, 2025 41.02%
Mar 31, 2025 41.10%
Dec 31, 2024 45.41%
Sep 30, 2024 26.80%
Jun 30, 2024 12.18%
Mar 31, 2024 -14.75%
Dec 31, 2023 7.71%
Sep 30, 2023 -303.80%
Mar 31, 2023 -22,294.26%
Dec 31, 2022 -16,097.23%
Sep 30, 2022 -13,611.32%
Jun 30, 2022 -4,457.83%
Mar 31, 2022 -19,541.63%
Dec 31, 2021 -31,251.43%
Sep 30, 2021 -24,844.44%
API Access

Krystal Biotech Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KRYS&period=max&api_key=YOUR_API_KEY